Delivery Order SPE2DB22D2009-SPE2DB25FL8WK

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,010.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,568,093,488 units of BRILINTA 90 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of May 1, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication BRILINTA 90 MG TABLET 60S. The contract, valued at $1,288.46, is a Firm Fixed Price Delivery Order with a completion date of July 7, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
This federal contract award, valued at $2,171.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of April 9, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,017.36, is for the delivery of the drug BRILINTA 90 MG TABLET 60S. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 15, 2025. The award is not associated with a set-aside designation, indicating open competition....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of BRILINTA 90 MG TABLET 60S, a prescription medication. The contract, valued at $1,354.65, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of August 22, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
This federal contract award, valued at $4,511.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a delivery order for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $1,072.56, was issued by the Defense Logistics Agency (DLA) to the pharmaceutical distributor AmerisourceBergen Drug Corp. The contract is for the delivery of 4,566,281,033 units of the cardiovascular medication BRILINTA 90 MG TABLET 60S. This is a firm-fixed-price delivery order with an ultimate completion date of October 31, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor with no set-aside designation, indicating open...
This federal contract award, valued at $1,241.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication, with a completion date of April 30, 2025. This contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,742.61, is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 15, 2025. This award is not associated with a set-aside designation, indicating open...
This federal contract award, valued at $1,016.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BRILINTA 90 MG TABLET 60S. The contract has a completion date of September 13, 2021 and is a firm-fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL8WK
    Delivery Order

This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL8WK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,968,430 units of the medication BRILINTA 90 MG TABLET 60S. The fixed-price delivery order contract has a ceiling value of $7,509.90 and a performance period ending on April 21, 2025. This award is not associated with a set-aside program and represents an open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract award supports the DLA's mission to provide medical supplies and pharmaceuticals to the U.S. military and other government agencies.

Generated 7/18/25, 10:00 AM